Curable composition, functional polymer hardened product, stack or device comprising functional polymer membrane, amide compound, and manufacturing method thereof

Patent metadata

Field	Value
Publication number	US-2017152331-A1
Application number	US-201715430941-A
Country	US
Kind code	A1
Filing date	Feb 13, 2017
Priority date	Aug 28, 2014
Publication date	Jun 1, 2017
Grant date	—

Abstract

Provided are a curable composition including an amide compound that is represented by Formula (1) below and of which a density of sulfonic acid is 3.9 milliequivalent/g or greater, a functional polymer hardened product, a stack or a device including a functional polymer membrane, an amide compound, and a manufacturing method thereof.

m represents an integer of 1 or greater, n represents an integer of 2 or greater, L 1 represents a m+1-valent linking group, and L 2 represents an n-valent linking group. R 1 represents a hydrogen atom or an alkyl group, and R 2 represents —SO 3 − M + or —SO 3 R 3 (R 3 represents an alkyl group or an aryl group). Here, in a case where there are plural R 2 's, not all of the R 2 's are —SO 3 R 3 . M + represents a hydrogen ion, an inorganic ion, or an organic ion.

First claim

What is claimed is:

1 . A curable composition comprising:
an amide compound that is represented by Formula (1) below and of which a density of sulfonic acid is 3.9 milliequivalent/g or greater,

in Formula (1), m represents an integer of 1 or greater; n represents an integer of 2 or greater; L 1 represents a m+1-valent linking group; L 2 represents an n-valent linking group; R 1 represents a hydrogen atom or an alkyl group; R 2 represents —SO 3 − 1\4 + or —SO 3 R 3 ; here, in a case where there are plural R 2 's, not all of the R 2 's are —SO 3 R 3 ; M + represents a hydrogen ion, an inorganic ion, or an organic ion; and R 3 represents an alkyl group or an aryl group.

2 . The curable composition according to claim 1 , that is used for forming a functional polymer membrane.

3 . The curable composition according to claim 1 , that is used for forming an ion-exchange membrane.

4 . The curable composition according to claim 1 ,
wherein the amide compound is an amide compound represented by Formula (2) below,

in Formula (2), LL 1 represents an alkylene group; and n, R 1 , L 2 , and M + respectively have the same meanings as n, R 1 , L 2 , and M + in Formula (1).

5 . The curable composition according to claim 1 ,
wherein the amide compound is an amide compound represented by Formula (3) below,

in Formula (3), m1 represents an integer of 1 to 5; and n, R 1 , R 2 , and L 2 respectively have the same meanings as n, R 1 , R 2 , and L 2 in Formula (1).

6 . The curable composition according to claim 1 ,
wherein a molecular weight of the amide compound is 900 or less.

7 . The curable composition according to claim 1 , further comprising:
a polymerization initiator.

8 . The curable composition according to claim 1 , further comprising:
a solvent.

9 . A functional polymer hardened product obtained by performing polymerization hardening reaction on the curable composition according to claim 1 .

10 . The functional polymer hardened product according to claim 9 , which is a functional polymer membrane.

11 . The functional polymer hardened product according to claim 10 , which is an ion-exchange membrane.

12 . A stack, comprising:
the functional polymer hardened product according to claim 9 .

13 . A device, comprising:
the functional polymer hardened product according to claim 9 .

14 . A manufacturing method of an amide compound, comprising:
manufacturing a compound represented by Formula (2) below from a compound represented by Formula (4) below,

in Formulae (2) and (4), n represents an integer of 2 or greater; LL 1 represents an alkylene group; L 2 represents an n-valent linking group; R 1 represents a hydrogen atom or an alkyl group; M + represents a hydrogen ion, an inorganic ion, or an organic ion; and R 3 represents an alkyl group or an aryl group.

15 . A manufacturing method of an amide compound, further comprising:
manufacturing the compound represented by Formula (4) according to claim 14 from a compound represented by Formula (5) below,

in Formula (5), n, R 3 , LL 1 , and L 2 respectively have the same meanings as n, R 3 , LL 1 , and L 2 in Formula (4).

16 . A compound represented by Formula (6) below,
wherein a density of sulfonic acid is 3.9 milliequivalent/g or greater,

in Formula (6), LL 1 represents an alkylene group; LL 2 represents an alkylene group; R 1 represents a hydrogen atom or an alkyl group; R 2a and R 2b each independently represent —SO 3 − M + or —SO 3 R 3 ; here, not both of R 2a and R 2b are —SO 3 R 3 ; M + represents a hydrogen ion, an inorganic ion, or an organic ion; and R 3 represents an alkyl group or an aryl group.

17 . A compound represented by Formula (7) below,

in Formula (7), LL 1 represents an alkylene group; LL 2 represents an alkylene group; R 1 represents a hydrogen atom or an alkyl group; and R 3 represents an alkyl group or an aryl group.

Assignees

• Fujifilm Corp

Inventors

• Iizuka Yuusuke
• Sano Satoshi
• Kodama Keisuke
• Inomata Sotaro
• Kaminaga Kuniyuki

Classifications

• C07C309/15 Primary

  the nitrogen atom of at least one of the amino groups being part of any of the groups [IMAGE cpc-sch-C07C-0975.gif], X being a hetero atom, Y being any atom · CPC title

• B01D2325/42

  Ion-exchange membranes · CPC title

• B01D2323/34

  Use of radiation · CPC title

• B01D71/82

  characterised by the presence of specified groups, e.g. introduced by chemical after-treatment · CPC title

• B01D71/56

  Polyamides, e.g. polyester-amides · CPC title